- Home
- EPOW vs CRIS Comparison
EPOW vs CRIS Comparison
Compare EPOW & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPOW | CRIS |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 20.6M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EPOW | CRIS |
|---|---|---|
| Price | $0.43 | $5.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 52.9K | ★ 182.1K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.40 | $0.18 |
| 52 Week High | $1.86 | $6.74 |
Technical Indicators
Market Signals| Indicator | EPOW | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 33.22 | 68.47 |
| Support Level | N/A | $0.66 |
| Resistance Level | $0.72 | $5.50 |
| Average True Range (ATR) | 0.04 | 0.49 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 17.88 | 51.01 |
Price Performance
Historical ComparisonAbout EPOW Sunrise New Energy Co. Ltd
E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. It operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, the Group also operates a knowledge-sharing platform business. Its reportable operating segments are: Graphite anode business, which generates the maximum revenue, and Knowledge sharing and enterprise business. Substantially all of the Group's revenue is derived in the People's Republic of China (the PRC).
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.